Work reimagined: a two-geared approach to reopening and transforming your business

Successfully returning to the physical workplace is the priority. But recovery from the COVID-19 crisis is also an opportunity to reframe your organization’s future. In Germany, car dealerships are reopening their showrooms; in Bangladesh’s garment factories, the sewing machines are restarting; and across much of the US, companies from chipmakers to jet manufacturers are cautiously … More Work reimagined: a two-geared approach to reopening and transforming your business

Six ways general counsel can respond to crisis

As issues arise in many areas of the business because of the crisis, it is critical for the legal department to be as prepared as possible. Whether it’s a global pandemic, economic shock or natural disasters, global organizations’ crisis planning comes sharply into focus when confronting these challenges. For many legal teams who are busy … More Six ways general counsel can respond to crisis

Employee health: six key questions for your legal team

During an event like the COVID-19 pandemic, employers must determine their responsibilities, along with those of employees and subcontractors. When a health crisis hits, such as the COVID-19 global pandemic, employers must reassess their obligations to employee health and other stakeholders under the regulatory regimes in which their organization operates. Determining responsibilities is always a … More Employee health: six key questions for your legal team

COVID-19: Five ways to maintain continuity and reshape for resilience

Global companies have to be predictive and proactive in their decision-making to preserve business continuity and build enterprise resilience. As companies navigate the ongoing COVID-19 crisis, there are a number of key issues corporate leaders should be thinking about, as well as steps they can take to not only react to severe business shocks now … More COVID-19: Five ways to maintain continuity and reshape for resilience

The Interbank Offered Rate (IBOR) transition has started

Is the swiss industry ready for the world without IBOR and how does the alternative look like? The EY industry roundtable held on 18th September in Geneva was an excellent opportunity to measure the IBOR transition progress of the Swiss market. We have gathered more than 75 participants representing diverse types of institutions, functions and … More The Interbank Offered Rate (IBOR) transition has started

Data privacy considerations in telecommunications M&A: do you know your risk?

Global M&A activity among telecommunications (telco) companies reflects the ongoing transformation impacting the sector in response to increasing competitive intensity, evolving consumer behaviors and disruption from so-called “over-the-top” (OTT) players, which deliver audio, video or other media over the internet without the involvement of a multiple system operator in the control or distribution of the … More Data privacy considerations in telecommunications M&A: do you know your risk?

The evolution in self-driving vehicles: Trends and implications for the insurance industry

Read the full report here. A number of social, economic and technological trends are working together to disrupt mobility. The automotive industry, in particular, is experiencing a massive amount of change. In the not-too-distant future, fully autonomous vehicles will be the norm rather than the exception, redefining urban mobility as we know it — and … More The evolution in self-driving vehicles: Trends and implications for the insurance industry

Connected cars: Navigating the competition law implications

A defining element of the digital economy is that services are provided for free to consumers. The quid pro quo is that the service supplier (for example, Google) can monetize the data generated by the consumer, often in ways in which the consumer is not fully aware. Based on this business model, future car manufacturers … More Connected cars: Navigating the competition law implications

Beyond borders: Biotechnology report 2017 – Staying the course

It was supposed to be a bad year for biotech. For this sector, the simplest of truisms has always held: what goes up must eventually come down. Markets peaked in 2015 and declined in 2016; payer pressure and US election year rhetoric weighed on the sector; drug approvals fell sharply; and biotech companies faced a … More Beyond borders: Biotechnology report 2017 – Staying the course